Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Assets (2016 - 2025)

Historic Assets for National Research (NRC) over the last 16 years, with Q3 2025 value amounting to $135.7 million.

  • National Research's Assets rose 297.5% to $135.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.7 million, marking a year-over-year increase of 297.5%. This contributed to the annual value of $132.5 million for FY2024, which is 825.08% up from last year.
  • According to the latest figures from Q3 2025, National Research's Assets is $135.7 million, which was up 297.5% from $141.4 million recorded in Q2 2025.
  • National Research's 5-year Assets high stood at $157.5 million for Q4 2021, and its period low was $119.1 million during Q2 2024.
  • Its 5-year average for Assets is $136.5 million, with a median of $135.0 million in 2022.
  • Per our database at Business Quant, National Research's Assets surged by 3002.89% in 2021 and then crashed by 1718.87% in 2022.
  • Quarter analysis of 5 years shows National Research's Assets stood at $157.5 million in 2021, then decreased by 17.19% to $130.5 million in 2022, then decreased by 6.15% to $122.4 million in 2023, then grew by 8.25% to $132.5 million in 2024, then rose by 2.4% to $135.7 million in 2025.
  • Its Assets was $135.7 million in Q3 2025, compared to $141.4 million in Q2 2025 and $135.2 million in Q1 2025.